Methods and Results: H
H ydrogen peroxide (H 2 O 2 ), a diffusible reactive oxygen species (ROS), has been recognized as an important regulator of vascular tone and homeostasis under physiological and pathophysiological conditions. [1] [2] [3] As an endothelium-derived hyperpolarization factor, H 2 O 2 induces smooth muscle cell hyperpolarization and vasodilation in human coronary arterioles (HCAs) and adipose arterioles from subjects with coronary artery disease (CAD). [4] [5] [6] [7] Other studies have also demonstrated H 2 O 2 -induced hyperpolarization and dilation in normal human and animal arteries. 8 The mechanisms of H 2 O 2 -induced vasodilation have not been fully elucidated; however, 2 main types of K + channels in vascular smooth muscle cells (VSMCs), largeconductance Ca 2+ -activated K + (BK Ca ) channels and voltage-gated K + (K V ) channels, have been variably implicated in different vascular beds. 9 For instance, BK Ca channels contribute to H 2 O 2 -induced dilation in porcine coronary arteries. 10, 11 In contrast, 4-aminopyridine (4-AP)-sensitive K V channels mediate dilation to H 2 O 2 in canine coronary arteries, 12 rat coronary and mesenteric arteries, 12, 13 and porcine coronary resistance arteries. 14 Using coronary arterioles from CAD subjects, we found that H 2 O 2 opens smooth muscle BK Ca channels to elicit smooth muscle hyperpolarization and relaxation. 6, 7 The mechanisms of dilation by H 2 O 2 in subjects without CAD (non-CAD) versus those with CAD, as well as the functional consequences, remain unknown, but there is evidence that BK Ca and K V constitute 2 major K + currents in VSMCs isolated from non-CAD human arteries. 15 In addition to H 2 O 2 -induced activation of K + channels, excessive and prolonged elevation of ROS can exert differential effects on vascular K + channel function in disease. 9, [16] [17] [18] Depending on the sensitivity of individual K + channels and the oxidative species involved, ROS can activate, inhibit, or leave unaltered K + channel function. 9 For example, impaired functions of K V channels have been shown in various animal models of cardiovascular disease, while BK Ca channels may exhibit either gain or loss of function under pathophysiological conditions. 9 The disease-associated alteration of vascular K + channel function in humans is less well understood. 19 In this study, we tested the hypothesis that H 2 O 2 -elicited dilation involves different K + channels in non-CAD versus CAD arterioles, resulting in an altered vasodilatory response in CAD. Using an integrated approach comprising isolated vascular reactivity measurement, molecular and immunohistochemical analyses, and electrophysiology, we assessed the role of 2 different types of K + channels (BK Ca versus K V ) in H 2 O 2 -induced dilation of human arterioles from non-CAD and CAD subjects. We further identified specific K V 1 channels, the major vascular K V channel subfamily, in VSMCs and examined their functional contribution to H 2 O 2 -induced dilation. The impact of CAD on the function of K V 1 channels and potential underlying mechanisms were also determined.
Methods

Tissue Acquisition
Fresh human adipose tissues (pericardial, visceral, and subcutaneous, n=24, 68, and 28, respectively) were obtained as discarded surgical specimens from a total of 120 patients undergoing abdominal surgeries or cardiopulmonary bypass procedures and unused whole hearts (n=14) acquired from Donor Network. Patient demographic information is summarized in Online Table I .
Videomicroscopy
Arterioles (internal diameter, 100-250 μm) were carefully dissected from human adipose tissues and cannulated with 2 glass micropipettes for measurements of diameter with a video system as previously described. 20 Arterioles were preconstricted with endothelin-1 to ≈30% to 50% of the baseline internal diameter. Relaxation responses to cumulative addition of H 2 O 2 (1-100 μmol/L) to the vessel bath were determined in the absence and presence of 30 minutes preincubation with various modulators, including BK Ca and K V blockers. At the end of each experiment, papaverine (100 µmol/L) was added to determine the maximal internal diameter for normalization of dilator responses. Unless otherwise stated, experiments were performed on endothelium-intact arterioles and in the presence of N G -nitro-Larginine methyl ester (100 μmol/L) and indomethacin (10 μmol/L).
Enzymatic Isolation of Vascular Cells
VSMCs were enzymatically dissociated from arteries as previously described. 7, 20 Cells were placed on ice and used the same day.
Patch-Clamp Recording of K + Currents
Whole-cell K + currents were measured in freshly dissociated smooth muscle cells using the standard (ruptured patch) or perforated patchclamp method as previously described. 15, 21 The pipette solution contained (in mmol/L) 90 potassium aspartate, 30 KCl, 20 NaCl, 1 MgCl 2 , 1 Mg-ATP, 1 EGTA, and 10 HEPES (pH 7.2 with KOH). The bath solution was composed of (in mmol/L) 140 NaCl, 5 KCl, 0. • K V 1 family channels are known to be redox regulated.
• K V 1.5 channels in preclinical models mediate the actions of H 2 O 2 and connect cardiac metabolism to myocardial blood flow.
What New Information Does This Article Contribute?
• H 2 O 2 induces potent smooth muscle-mediated vasodilation through BK Ca and K V (especially K V 1.5) channels in adipose arterioles from human subjects without CAD.
• H 2 O 2 -elicited dilation is reduced in arterioles from patients with CAD and is accompanied by a loss of K V 1.5-dependent dilation but not BK Cadependent dilation.
• K V 1.5 cell surface localization and channel currents are reduced in vascular myocytes from subjects with CAD, with no change of mRNA or total cellular protein expression.
Endothelium-derived vasodilator factors such as NO and prostacyclin play a key role in regulation of vascular tone and homeostasis under normal conditions. In subjects with CAD, the primary mediator changes to H 2 O 2 in various vasodilator responses especially flow-mediated dilation. This study shows a reduced smooth muscle-mediated dilation to H 2 O 2 in arterioles from CAD compared with non-CAD subjects, resulting from a transition from a combined BK Ca -and K V (K V 1.5)-mediated vasodilation to a dilation mediated predominantly by BK Ca . Therefore, the onset of cardiovascular disease not only changes the primary endothelial vasodilators (NO to H 2 O 2 ) but also affects smooth muscle K + channels that respond to vasodilator factors. The loss of K V 1.5-mediated dilation to H 2 O 2 or other vasodilators may represent an important mechanism contributing to microvascular dysfunction in humans with CAD or other cardiovascular diseases.
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1 MgCl 2 , 5 glucose, and 10 HEPES (pH 7.4 with NaOH). Paxilline (100 nmol/L) was added in the bath solution to further minimize BK Ca currents and thus allow relative isolation of K V currents. Unless otherwise stated, all chemicals were applied to the bath through perfusion. Experiments were performed at room temperature.
RNA Extraction and Reverse TranscriptionPolymerase Chain Reaction
Total RNA from human adipose arteries and arterioles (200-500 μm) was extracted, and cDNA was synthesized. The cDNA was amplified using a touch-down polymerase chain reaction (PCR) protocol with gene-specific primers. Relative K V α1.5 gene expression was quantified with real-time PCR using pooled sample cDNA from each non-CAD and CAD group. For primer sequences refer to Online Table III .
Immunoblotting
Human adipose arteries and arterioles (200-500 µm) and coronary arteries (200-2,000 µm) were dissected, and membrane proteins were prepared with a differential centrifugation method as described previously. 22 Protein samples (20 µg) were separated by 10% SDS-PAGE. Membranes were blotted with a primary antibody against a specific K V 1 α-subunit, BK Ca , and Na 
Immunohistochemistry
Freshly dissected arteries were embedded in OTC compound, frozen on dry-ice, and cut into 10-μm sections. 20 Sections were blocked with 5% normal goat serum and probed with a monoclonal or polyclonal antibody against a specific K V 1 α-subunit (1:200 dilution), followed by secondary probing with an Alexa Fluor 568-conjugated goat antirabbit or anti-mouse IgG antibody (1:400 dilution). Sections were counterstained with DAPI and mounted in SlowFade antifade medium (Invitrogen). Images were immediately captured using a confocal fluorescence microscope (model A1-R, Nikon).
Immunocytochemistry
Freshly isolated VSMCs were fixed with 4% paraformaldehyde and permeabilized with 0.1% saponin. 7 Cells were then incubated either with a monoclonal or polyclonal antibody specific to a K V 1 α-subunit (1:200 dilution), followed by an appropriate goat secondary antibody conjugated with Alexa Fluor 488 (1:400 dilution). Cells were then mounted and images were captured using a confocal fluorescence microscope.
Chemicals
Diphenylphosphine oxide-1 (DPO-1), paxilline, and 5-(4-phenylbutoxy)psoralen (Psora-4) were obtained from Tocris; stromatoxin from Alomone; and tris(2-carboxyethyl)phosphine from Thermo Scientific. All other chemicals were purchased from Sigma. Stock solutions were prepared in distilled water, except for the following: 1-benzyl-4-pentylimino-1,4-dihydroquinoline, DPO-1, phenoxyalkoxypsoralen-1, paxilline, and Psora-4 (ethanol); 4-AP (HCl, pH readjusted to 7.4); and indomethacin (0.1 mol/L Na 2 CO 3 ).
Statistical Analysis
All data are presented as mean±SEM. Comparisons of concentrationresponse curves of isolated vessels were performed using 2-way repeated-measures ANOVA, followed by the Student-Newman-Keuls multiple-comparison test. Other comparisons were made using 1-way ANOVA or Student t test. P values <0.05 were considered statistically significant.
Results
K V Channels Contribute to H 2 O 2 -Induced Vasodilation in Non-CAD but Not in CAD Human Arterioles
Previous studies have shown impaired function of smooth muscle K + channels in animal models of vascular disease, such as hypertension and metabolic syndrome. 9, [16] [17] [18] It remains largely unknown whether K + channel function is similarly altered in humans. We first examined the role of BK Ca and K V channels in H 2 O 2 -induced dilation using adipose arterioles Figure IC ) is similar to those reported in canine 12 and human 7 coronary arterioles. In CAD arterioles ( Figure 1B ), H 2 O 2 -induced dilation was also blocked by paxilline (% dilation at 10 μmol/L, 1±6 versus 41±8 in CAD control, % dilation at 50 μmol/L, 40±7 versus 76±6 in CAD control, n=5; P<0.05). However, the dilation was not affected by 4-AP. These results indicate that K V channel-dependent dilation in response to H 2 O 2 is impaired in CAD, whereas consistent with our previous findings in coronary arterioles, 7 BK Ca remains functional in disease. Incubation of arterioles with 4-AP induced significant vasoconstriction in non-CAD but not in CAD subjects (Online Table II ), indicating that K V channels regulate basal vascular tone in non-CAD subjects. Treatment of adipose arterioles with exogenous catalase (1000 U/mL), an H 2 O 2 metabolizing enzyme, also completely abolished H 2 O 2 -induced dilation (Online Figure II ). An important mechanism by which H 2 O 2 elicits biological effects is through oxidizing thiol groups of its target proteins. 23 Indeed, dithiothreitol (3 mmol/L), a membrane-permeant and thiolspecific reducing agent, quickly reversed H 2 O 2 -induced dilation within 3 to 5 minutes (% dilation at 100 μmol/L H 2 O 2 , 1±3 versus 83±4 before dithiothreitol, n=3; P<0.05). However, tris(2-carboxyethyl)phosphine (5 mmol/L), a membraneimpermeable thiol reducing agent, had no effect. These data further confirm that H 2 O 2 is a potent, specific, and reversible smooth muscle relaxant, a characteristic consistent with its putative important signaling role in human arterioles.
H 2 O 2 -Induced Dilation Involves Smooth Muscle Hyperpolarization and Is Redox Sensitive
Detection of K V 1 Subunit mRNA and Protein Expression in Non-CAD Human Arteries
The specific type(s) of K V channels expressed in human arteries remains largely unexplored. We focused on K V 1 channels (shaker-related family), which are functionally significant K V channels in most animal vascular beds studied 24 and are 4-AP sensitive. Figure 3 shows mRNA expression of different K V 1 channel subunits in non-CAD adipose arterioles as assessed by reverse transcription-PCR. Several K V 1 α (pore forming)-subunits, including 1.1, 1.2, 1.4, 1.5, and BK Ca α-subunits, were consistently found in different samples, including denuded vessels (n=5), with K V 1.5 being the most abundantly expressed K V 1 α-subunit. The 2 other K V 1 α-subunits (1.3 and 1.6) were variably expressed in some but not all samples. We also detected the α-subunits that form a second type of vascular K V channels (2.1 and 9.3), K V 1 β (accessory)-subunits (1.1-1.3), although these subunits were not further pursued in the following immunoblotting assays.
Using subunit-specific antibodies, we examined the protein expression of K V 1.1 to 1.6 and BK Ca α-subunits in the membrane fraction prepared from non-CAD adipose arteries/arterioles (n=2). Consistent with mRNA expression data, K V 1.4 and 1.5 and BK Ca channels were readily detected at the protein level (Figure 4) . K V 1.3 and 1.6 proteins were also found in non-CAD arteries/arterioles, whereas K V 1.1 and 1.2 A B Figure 2 . Effects of nitric oxide synthase (NOS) and cyclooxygenase inhibition, endothelium denudation, and high K + on hydrogen peroxide (H 2 O 2 )-induced dilation in non-coronary artery disease (non-CAD) human adipose arterioles. A, The dilation was not affected by the NOS inhibitor N G -nitro-Larginine methyl ester (L-NAME; 100 μmol/L), the cyclooxygenase inhibitor indomethacin (Indo; 10 μmol/L), alone or in combination. n=6 vessels per group. B, The dilation was not affected by removal of the endothelium but was abolished by high K + (60 mmol/L). n=3 vessels per group; *P<0.05 vs control. February 17, 2017
proteins were not detected. The absence of K V 1.2 in human vascular samples was unexpected because it is a dominant K V 1 α-subunit that forms channel complex with K V 1.5 in rat cerebral arteries. 25 The failure to detect K V 1.1 or 1.2 in arterial samples does not seem to result from nonreactivity of the antibodies used because abundant expression of these 2 proteins was observed in human brain parallel controls.
K V 1 channels (except K V 1.6) are expressed as mature N-glycosylated proteins in native tissues such as brain. 26 As shown in Figure 4 , the apparent molecular mass values of K V 1 proteins in human brain or adipose arterial tissues were ≈75 kDa (1.1 and 1.2), doublet around 75 kDa (1.3 and 1.5), doublet around 110 kDa (1.4), and 60 kDa (1.6). Whereas K V 1.6 seems to be unmodified, K V 1.1 to 1.5 channels are of higher apparent molecular weights corresponding to glycosylated or other post-translationally modified forms as previously reported in the brain or vascular tissues.
25,27
Detection of K V 1 Subunit Protein Localization in Non-CAD Human Arteries
To determine the cell type-specific localization of K V 1 α-subunits in human arteries, we performed frozen-section immunofluorescence staining of human adipose arterioles. K V 1 proteins were labeled with red Alexa-568-conjugated secondary antibody and images were captured with a confocal fluorescence microscope. Thus, autofluorescence intrinsic to the internal elastic lamina can be detected in the green fluorescein isothiocyanate channel and used to visually divide the endothelium and smooth muscle layers. As shown in Figure 5A , K V 1.5 and to a less amount K V 1.4 proteins were readily detected in the smooth muscle layer. Surprisingly, these 2 proteins were also abundantly expressed in endothelial cells (ECs). A small amount of K V 1.3 and 1.6 was also detected in ECs.
The limited resolution power of immunohistochemistry did not allow individual VSMCs to be distinguished even at ×600 magnification. To further examine the subcellular localization of K V 1 proteins, we freshly dissociated VSMCs from adipose arterioles for immunocytochemistry. As shown in Figure 5B , K V 1.5 protein was predominantly localized on the plasma membrane of dissociated smooth muscle cells. Interestingly, K V 1.5 was also detected on the nuclei envelope, a cellular structure that is continuous with endoplasmic reticulum and serves as a site of initial protein synthesis for some membrane proteins.
28,29 K V 1.4 protein was also detected in VSMCs, however, the expression of K V 1.4 protein was lower than that of K V 1.5 and also seemed largely intracellular.
K V 1.5 as a Major Functional K V 1 Channel in H 2 O 2 -Induced Dilation of Non-CAD but Not CAD Human Arterioles
Given that K V 1.5 is 4-AP sensitive and abundantly expressed in VSMCs of human adipose arteries/arterioles, we subsequently Figure III) . Together, these results suggest that K V 1.5 serves as a major 4-AP-sensitive K V 1 channel contributing to H 2 O 2 -induced dilation in non-CAD adipose arterioles.
Compared with non-CAD arterioles, there was a slight but statistically significant reduction of H 2 O 2 -induced dilation in CAD (% dilation at 10 μmol/L H 2 O 2 , 40±4 versus 59±4 in non-CAD, % dilation at 50 μmol/L, 71±3 versus 86±2 in non-CAD, n=18 per group; P<0.05; Figure 7A ). In contrast to non-CAD arterioles (Figure 6 ), K V 1.5 channel blockade by either DPO-1 or Psora-4 did not alter H 2 O 2 -induced dilation in CAD ( Figure 7B and 7C) , a finding consistent with ineffectiveness of 4-AP in CAD arterioles. These results indicate a loss of functional K V channels, smooth muscle K V 1.5 in particular, in human arterioles during CAD.
Potential Mechanism of Impaired K V 1.5 Function in CAD Human Arteries
We further examined the potential mechanisms responsible for impaired K V 1.5 function in CAD vessels. By immunostaining of freshly dissociated VSMCs, we found that the plasma membrane staining of K V 1.5 protein was markedly reduced in CAD subjects ( Figure 8A ). Analysis of plasma membrane/ cytoplasmic ratio of K V 1.5 fluorescence further confirmed reduced plasma membrane distribution of this protein in VSMCs from CAD subjects when compared with non-CAD subjects (1.83±0.12 and 2.62±0.15, respectively; P<0.05). Intriguingly, K V 1.5 immunofluorescence from the nuclear envelope was comparable in CAD versus non-CAD samples.
In contrast to K V 1.5, BK Ca protein localization on the plasma membrane was maintained in VSMCs from CAD subject when compared with non-CAD subjects (Online Figure IVA ; calculated plasma membrane/cytoplasmic ratio, 4.03±0.32 and 3.07±0.18, respectively). We also examined K V 1.5 and BK Ca immunofluorescence in ECs isolated from adipose arterioles of non-CAD and CAD subjects (Online Figure IVA and IVB) . Whole-cell immunofluorescence of K V 1.5 in ECs seemed comparable between CAD and non-CAD, although further analysis of plasma membrane/cytoplasmic ratio is difficult because of small cell size of isolated ECs. The immunoreactivity for BK Ca channel α-subunits in ECs was minimal, which is in line with our previous findings that mRNA transcripts of BK Ca were not detected in isolated ECs from HCAs. 7 The specificity of K V 1.5 antibodies was confirmed by using human embryonic kidney 293 cell cells with and without K V 1.5-DDK transfection and double-staining technique (Online Figure V) .
Using end point reverse transcription-PCR analysis, the mRNA level of K V 1.5 in CAD vessels was comparable to that of non-CAD tissues when normalized to the housekeeping gene β-actin ( Figure 8B ). These results were further confirmed by the quantitative analysis of mRNA expression using real-time PCR ( Figure 8B , bar graph). Analysis of relative mRNA expression of K V 1.5 normalized to the mean of 2 housekeeping genes (β-actin and ATP5o) did not show marked change in non-CAD and CAD vessels (intact n=6 per group and denuded n=4 per group). A slight increase (7%) in intact CAD vessels but a moderate decrease (26%) in denuded CAD vessels was observed.
We also compared the expression of K V 1.5 protein in the membrane fraction of HCAs from non-CAD and CAD patients ( Figure 8C ). Because vessels collected from CAD adipose tissues were usually limited and were not sufficient for membrane protein preparation, HCAs were used instead for these experiments. Our recent studies have shown that human conduit and resistance arteries express a similar profile of K V 1 channels at both mRNA and protein levels. 30 The average protein expression level of K V 1.5 subunits normalized to Na + / K + -ATPase showed a trend toward an increase (but not statistically significant) in patients with CAD compared with those without (n=4 non-CAD and CAD subjects, respectively), although in 1 sample (out of 4) from CAD patients the level of K V 1.5 channel expression was much lower than average. The protein expression of BK Ca did not differ in the 2 groups.
We next examined whole-cell K + currents in VSMCs freshly dissociated from non-CAD and CAD adipose arterioles ( Figure 8D ). In non-CAD VSMCs, progressive depolarizing steps from a holding potential of −70 mV elicited outward currents at membrane potentials positive to −40 mV that were subsequently reduced by DPO-1 (1 μmol/L). Compared with non-CAD, baseline K + currents in CAD were lower. Although K + currents were further reduced by DPO-1 in CAD, DPO-1-sensitive current density was markedly reduced when compared with non-CAD. Because K + currents were recorded with low-Ca 2+ pipette and bath solutions and in the presence of the BK Ca channel blocker paxilline (100 nmol/L), the contribution of BK Ca to whole-cell K + currents was minimal. Recording of K V currents was also confirmed by the findings that 4-AP concentration dependently decreased the outward K + currents (Online Figure VI) . Together, the above results suggest that mainly the reduced plasma membrane expression of smooth muscle K V 1.5 subunits, rather than a change of mRNA or total protein, contributes to impaired vasomotor function of K V 1.5 channels in human arteries with CAD.
Discussion
The major new findings of this study are 3-fold. First, H 2 O 2 induces potent endothelium-independent vasodilation in adipose arterioles from non-CAD subjects that is largely mediated by BK Ca and K V channels. Second, K V 1.5 is the major type of smooth muscle K V 1 channel responsible for K V -dependent H 2 O 2 dilation in non-CAD arterioles. Third, the H 2 O 2 -elicited response is reduced in CAD arterioles and is accompanied by a loss of K V (especially K V 1.5), but not BK Ca -dependent dilation. The impaired function of K V 1.5 may result from reduced cell surface localization of the channel protein without significant change of mRNA or total protein expression.
Together, these results demonstrate a transition from BK Caand K V -mediated vasodilation toward a BK Ca -predominant mechanism of dilation in the human microcirculation during CAD. Although the pathophysiological significance of this K + channel transition remains to be explored, the loss of K V 1.5-mediated dilation to H 2 O 2 or other vasodilators may represent an important mechanism contributing to microvascular dysfunction in humans with CAD or other vascular diseases.
31-33
Smooth Muscle K + Channels in H 2 O 2 -Induced Dilation
Using HCAs from subjects with CAD, we previously reported that H 2 O 2 induces vasodilation by activating smooth muscle BK Ca channels, an effect secondary to H 2 O 2 -induced dimerization of protein kinase G. 7 BK Ca channels have also been implicated in H 2 O 2 -induced dilation in different vascular beds such as porcine coronary arteries. 10, 11 However, other studies indicate that K V channels but not BK Ca channels contribute to the dilatory effect of H 2 O 2 in canine and rat coronary arteries. 12 In this study, we found that H 2 O 2 induces high-K + -sensitive dilation in non-CAD adipose arterioles that is inhibited by blockers of both BK Ca (paxilline and iberiotoxin) and K V channels (4-AP). Furthermore, a combination of BK Ca and K V channel blockers almost completely abolished H 2 O 2 -induced dilation (≤30 µmol/L H 2 O 2 ), indicating that both BK Ca and K V mediate H 2 O 2 -induced dilation in non-CAD human arterioles. The mechanisms by which H 2 O 2 dilation involves distinct K + channels in different species or vascular beds remain to be established.
There is evidence that endothelial pathways contribute to vasomotor effects of H 2 O 2 , including cyclooxygenase-derived prostacyclin. 34 However, in human adipose arterioles, H 2 O 2 -induced dilation was not affected by inhibition of either NO and cyclooxygenase or endothelial denudation, confirming that the dilation is mostly smooth muscle dependent.
Membrane-permeant thiol reducing agent dithiothreitol completely blocked H 2 O 2 -induced dilation in human adipose arterioles, whereas membrane-impermeable thiol reagent failed to reverse the dilation. These data support an H 2 O 2 -mediated redox modification of K + channels proposed earlier 12 but further suggest an intracellular site of action. Indeed, H 2 O 2 can alter the activities of ion channels such as L-type Ca 2+ channel 35 and ATP-sensitive K + channel. 36 H 2 O 2 also activates smooth muscle K V 2.1 channels in rat mesenteric arteries through a similar mechanism via S-glutathionylation. 13 It remains to be determined whether H 2 O 2 -induced dilation involves redox modification of K V channels or alternatively other intermediate signaling proteins as we reported previously for protein kinase G in H 2 O 2 -induced BK Ca activation.
7
K V 1 Channel Subtypes in Human Vasculature
The expression of specific K V subunit channel gene products and proteins varies greatly among species and vascular beds, 24 and the molecular identity of K V channels, especially 4-APsensitive K V 1 channels, in the human vasculature remains largely unknown. Using reverse transcription-PCR analysis of mRNA transcripts, we consistently detected K V α1.1, 1.2, 1.4, 1.5, 2.1, 9.3, and K V β1.1 to 1.3 in both intact and denuded adipose arterioles from non-CAD subjects, although sample-to-sample variations were noted for K V α1.3 and 1.6 ( Figure 3 ). Among 6 K V 1 α-subunits, K V 1.3 to 1.6 but not K V 1.1 to 1.2 were also detected at the protein level (Figure 4 ). Immunofluorescence assay of vessel sections and freshly dissociated VSMCs further revealed that K V 1.5 is the main subunit expressed on the plasma membrane of VSMCs. K V 1.4 seems mainly intracellular in adipose VSMCs. We also found K V 1.5, 1.4, and to a much less extent, K V 1.3 and 1.6, in the endothelium of adipose arterioles.
Pharmacological studies further demonstrated that K V 1.5 is a major functional K V 1 channel responsible for H 2 O 2 -induced dilation in non-CAD adipose arterioles ( Figure 6 ). This is based on the findings that K V 1.5-selective blocker DPO-1 reduced H 2 O 2 -induce dilation by the same extent as the general K V 1 blocker 4-AP. K V 1.5 siRNA also significantly reduced H 2 O 2 -induced dilation in non-CAD arterioles (Online Figure III) . Selective K V 1.3/1.5 blocker Psora-4 caused a similar rightward shift, whereas K V 1.3 blocker failed to affect the dilation. Psora-4 further reduced the maximal dilation to 100 μmol/L H 2 O 2 , which may be because Psora-4 is >20-fold more potent for K V 1. In non-CAD adipose arterioles, the dilation induced by the highest concentration of H 2 O 2 (100 µmol/L) was blocked by high K + but only slightly blocked by the combination of BK Ca and K V channel blockers, indicating the potential involvement of other K + channels. Several studies reported that K V 2 α-subunits or K V 2.1/9.3 heterotetramers contribute to the 
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regulation of vascular tone in rodent arteries. 39, 40 In this study, we detected vascular K V 2.1 mRNA (Figure 3 ) and protein expression (data not shown); however, selective K V 2.1 and K V 2.1/9.3 blocker stromatoxin did not alter H 2 O 2 -induced dilation in non-CAD arterioles (Online Figure I) . Redox-sensitive K V 7 channels represent another potential candidate, but a recent study indicate that they do not contribute to H 2 O 2 dilation in porcine coronary arteries. 41 Further investigations are needed to elucidate the role of other K + channels in human arterioles.
Alteration of K + Channel Function in CAD
Compared with non-CAD arterioles, H 2 O 2 -induced dilation was significantly reduced in CAD arterioles ( Figure 7A ). Furthermore, H 2 O 2 -induced dilation of CAD adipose arterioles was inhibited by only BK Ca but not K V channel blockers. To the best of our knowledge, this is the first report on the recruitment of different smooth muscle K + channels in H 2 O 2 -induced vasodilation from health to disease. The expression of BK Ca mRNA and protein, as well as protein localization, was not altered by CAD, a finding consistent with that of our previous study in HCAs. 7 We, thus, conclude that BK Ca channels remain functional in CAD arterioles. In other vascular beds or species, the effect of disease on the expression and function of BK Ca channels remains complex or controversial. 9, [16] [17] [18] For example, BK Ca channel activity is increased in human VSMCs obtained from coronary atherosclerotic lesions. 42 Animal studies support that BK Ca channel expression is increased in hypertension, possibly as a compensatory mechanism for the downregulation of K V channel expression. 18 However, BK Ca activity is reduced by exposure to high glucose or high concentrations of H 2 O 2 43 and in the porcine model of metabolic syndrome. 44 The reduction of H 2 O 2 -induced dilation in CAD arterioles can be mainly attributed to a loss of K V , especially K V 1.5, channel function in VSMCs. In contrast to non-CAD adipose arterioles, blocking of K V 1.5 or other K V 1 channels did not affect H 2 O 2 -induced dilation in CAD vessels (Figures 1 and 7) . Alternations in vascular K V channel function and expression have also been reported in other pathological conditions such as pulmonary 45 and systemic 46 hypertension, metabolic syndrome, 47 and diabetes mellitus, 48 but the identities of individual K V channels involved have not been well established. In human atrial myocytes, chronic atrial fibrillation, which is associated with oxidative stress or elevated ROS, reduces K V 1.5 (I Kur ) expression. 49 The precise mechanisms of impaired K V function under pathological conditions remain poorly understood. By examining K V 1.5 mRNA/protein expression and subcellular localization and K V 1.5 currents, we provide initial evidence that a reduced plasma membrane expression of K V 1.5 in VSMCs, rather than a change of mRNA and total protein synthesis, may be mainly responsible for the reduced K V 1.5 channel function in CAD. There is accumulating evidence that ion channels can recycle between the cytosol and cell membrane, and this dynamic recycling determines the number of functional channels present in the plasma membrane. [50] [51] [52] For example, a fraction of K V 1.5 channels on the cell membrane is rapidly internalized with a half time of ≈10 minutes and some return to the surface with a half time of ≈30 minutes. 52 In a HL-1 cell line, elevated ROS induces fairly rapid (within 60 minutes) reduction of surface expression of K V 1.5.
53 It remains to be tested in future studies whether prolonged elevation of ROS during CAD modulates cellular trafficking of smooth muscle K V 1.5 channels to reduce their membrane expression in human arterioles.
Potential Study Limitations
We found that K V 1.5 and K V 1.4 channels are expressed in ECs of human adipose arterioles. It is thus possible that H 2 O 2 may activate endothelial K V channels to induce endothelial hyperpolarization and subsequent vasodilation. Although the expression and function of endothelial K V channels are poorly understood, 17 there is evidence on the role of K V channels in endothelium-dependent hyperpolarization and dilation in arteries such as porcine coronary arteries 41, 54 and guinea pig coronary and carotid arteries. 55, 56 However, H 2 O 2 -induced dilation of adipose arterioles is largely smooth muscle dependent, and, therefore, the contribution of endothelial K V channels seems unlikely, at least in the present experimental settings. Nevertheless, we have not excluded a potential role for endothelial K V channels in the dilation to H 2 O 2 under other conditions (eg, endogenous H 2 O 2 generated in ECs).
This study used arterial tissues from human subjects with a variety of conditions that can affect vasodilator responses. By necessity, the non-CAD tissue samples are often collected from subjects with diverse diseases and thus are not true normal controls. To minimize potential confounding effects of underlying disease, only subjects with no more than 1 risk factor for CAD and no evidence of CAD were classified as non-CAD for this study. We further addressed this limitation with a statistical approach, identifying and controlling the influence of individual risk factors. Analysis of risk factors for CAD did not show an impact because of hypertension, hyperlipidemia, sex, or age on H 2 O 2 -induced dilation. There is an interaction between CAD and body mass index on EC 50 of H 2 O 2 response (Online Figure  VIII) ; however, this interaction may require further investigation in another cohort with a larger sample size. We also used adipose arterioles from several regions of the body; however, pilot studies indicate that H 2 O 2 -induced dilation was similar among visceral, subcutaneous, or pericardial adipose arterioles within non-CAD and CAD subject groups (Online Figure VII) .
A limitation of the functional studies with regard to H 2 O 2 -induced dilation is that we use a largely pharmacological approach, which may have off-target effects on other proteins such as other families of K V channels. To mitigate this possibility, we used several chemically distinct blockers of K V 1 channels, and the results obtained with these blockers invariably pointed toward an important role of K V 1.5 in H 2 O 2 -induced dilation of non-CAD adipose arterioles. In addition, we found that K V 1.5-targeted blockers had no significant effects in CAD arterioles, suggesting that any nonspecific effects should be minimal in this study. A recent study also reported a preferential inhibition of K V 1.5 by DPO-1 using VSMCs dissociated from wild-type versus K V 1.5 knockout mice. 57 Nevertheless, a molecular approach using K V 1.5 siRNA was also included to determine the specific role of K V 1.5 in H 2 O 2 -induced dilation of non-CAD arterioles.
Clinical Implications
Microvascular dysfunction has been implicated in a wide variety of pathologies, including obesity-associated insulin resistance, inflammation in visceral fat, and ischemic heart February 17, 2017 disease. [31] [32] [33] In the absence of CAD or its risk factors, traditional vasodilator factors (ie, NO and prostacyclin) are important for vasodilation in HCA and adipose arterioles. 19 With the onset of CAD, the dilation is switched to a new mechanism requiring the release of H 2 O 2 from ECs and subsequent smooth muscle hyperpolarization. [4] [5] [6] In this study, we demonstrate a reduced smooth muscle-mediated dilation resulting from a functional transition from BK Ca -and K V -mediated vasodilation to predominantly BK Ca -mediated mechanism of dilation in human arterioles during CAD. These results, thus, reveal another potentially important aspect of microvascular dysfunction where cardiovascular disease not only changes the primary endothelial vasodilators (NO to H 2 O 2 ) but also affects smooth muscle K + channels that respond to vasodilator factors. Our unpublished observations also show altered kinetics of dilation in healthy vessels in the presence of 4-AP, suggesting that in addition to reduced overall peak dilation in CAD versus health, the time-to-peak dilation may be altered because of changes in the expression/function of K V channels.
Impaired K V channel function will negatively impact local blood flow regulation in response to not only endothelial factors but also to tissue factors such as β-adrenergic transmitters and other metabolic factors. 9, 48, 58 This may induce deficit in regional blood supply and have detrimental effect on the function of tissues such as the heart where a tight coupling of blood perfusion and cell metabolism is essential. 58, 59 Regional organ perfusion, especially in the heart where near-maximal extraction of oxygen occurs at rest, requires tight, beat-to-beat regulation of blood flow to nearly instantaneously match oxygen supply with tissue's metabolic demand. In health, expression of different types and subtypes of K + channels and their axillary subunits with varying activation/inactivation kinetic properties contribute to this precise vasoregulatory control. With the onset/progression of disease, changes in function/expression of these channels would result in a dysregulation of blood flow and, in consequence, lead to a mismatch in oxygen supply and demand. Over time, these brief but repetitious states of tissue hypoxia could induce local inflammation, fibrosis, and eventually adverse tissue remodeling. 19 The molecular mechanisms of impaired K V function in CAD, as well as exact causal factors responsible for the K + channel remodeling, remain to be determined. A better understanding of these mechanisms may provide new strategies to improve or even restore normal K V channels and cardiovascular function. 
